Michael Schöll

Overview

Best Publications

• Brain charts for the human lifespan

  Unknown

  2075
  Citations

• PET Imaging of Tau Deposition in the Aging Human Brain

  Michael Schöll;Michael Schöll;Samuel N. Lockhart;Daniel R. Schonhaut;James P. O’Neil

  1286
  Citations

• Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.

  Thomas K. Karikari;Tharick A. Pascoal;Tharick A. Pascoal;Nicholas J. Ashton;Shorena Janelidze

  1260
  Citations

• Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

  Rik Ossenkoppele;Rik Ossenkoppele;Rik Ossenkoppele;Daniel R. Schonhaut;Daniel R. Schonhaut;Michael Schöll;Michael Schöll;Samuel N. Lockhart

  1221
  Citations

• Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

  Sebastian Palmqvist;Michael Schöll;Michael Schöll;Olof Strandberg;Niklas Mattsson

  901
  Citations

• Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology

  Nicholas J. Ashton;Tharick A. Pascoal;Thomas K. Karikari;Andréa L. Benedet;Andréa L. Benedet

  660
  Citations

• Amyloid biomarkers in Alzheimer's disease.

  Kaj Blennow;Kaj Blennow;Niklas Mattsson;Niklas Mattsson;Niklas Mattsson;Michael Schöll;Michael Schöll;Oskar Hansson

  543
  Citations

• Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease

  Jacob W. Vogel;Yasser Iturria-Medina;Olof T. Strandberg;Ruben Smith

  522
  Citations

• A multicentre validation study of the diagnostic value of plasma neurofilament light.

  Nicholas J. Ashton;Shorena Janelidze;Ahmad Al Khleifat;Antoine Leuzy

  512
  Citations

• Microglial activation and tau propagate jointly across Braak stages

  Tharick A. Pascoal;Andrea L. Benedet;Nicholas J. Ashton;Nicholas J. Ashton;Nicholas J. Ashton;Min Su Kang;Min Su Kang

  490
  Citations

• Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11C-Pittsburgh Compound B and 18F-FDG

  Stephen F. Carter;Michael Schöll;Ove Almkvist;Anders Wall

  483
  Citations

• Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders

  Rik Ossenkoppele;Rik Ossenkoppele;Gil D. Rabinovici;Ruben Smith;Hanna Cho

  468
  Citations

• Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative.

  Thomas K Karikari;Andréa L Benedet;Nicholas J Ashton;Juan Lantero Rodriguez

  338
  Citations

• The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease.

  Joel Simrén;Antoine Leuzy;Thomas K Karikari;Abdul Hye

  331
  Citations

• Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease

  Elena Rodriguez-Vieitez;Laure Saint-Aubert;Stephen F. Carter;Ove Almkvist;Ove Almkvist;Ove Almkvist

  304
  Citations

• Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease

  Alexis Moscoso;Michel J Grothe;Michel J Grothe;Nicholas J Ashton;Thomas K Karikari

  300
  Citations

• A walk through tau therapeutic strategies.

  Santosh Jadhav;Jesus Avila;Jesus Avila;Michael Scholl;Gabor G Kovacs

  277
  Citations

• Biomarkers for tau pathology

  Michael Schöll;Michael Schöll;Michael Schöll;Anne Maass;Niklas Mattsson;Nicholas J. Ashton

  225
  Citations

• Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.

  Alexis Moscoso;Michel J Grothe;Michel J Grothe;Nicholas J Ashton;Thomas K Karikari

  219
  Citations

• Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

  Annapaola Prestia;Anna Caroli;Wiesje M. van der Flier;Rik Ossenkoppele

  216
  Citations

• Imaging biomarkers in neurodegeneration: current and future practices

  Peter N. E. Young;Mar Estarellas;Emma Coomans;Meera Srikrishna

  209
  Citations

• Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer’s disease

  Ahmadul Kadir;Amelia Marutle;Daniel Gonzalez;Michael Schöll

  201
  Citations

• Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative

  Thomas K. Karikari;Andréa L. Benedet;Nicholas J. Ashton;Juan Lantero Rodriguez

  7
  Citations